The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting (opens in new tab)

The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting The Washington PostWeight-loss drugs can cut breast cancer risk by up to 30%, studies suggest The GuardianWeight-loss jabs ‘slash cancer risk and boost survival rates’ The TimesGLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30% U.S. News & World ReportWeight-loss drugs linked to lower breast cancer rates. What to know  USA Today